Assignee
JIANGSU MICROMEDMARK BIOTECH CO LTD
CN·9 granted patents·3 pending applications·22 citations·filing 2014–2022
Top patents by PatentIndex Score
12 records- 0188US9903002B2Non-coding RNA of Salmonella and identification and use thereofJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2014·Granted Feb 27, 2018·18 cites·4 claims
- 0287US10533173B2Precursor miRNA and applications in tumor therapy thereofJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2016·Granted Jan 14, 2020·4 cites·20 claims
- 0370US2023056466A1Novel precursor mirna and application thereof in tumor treatmentJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 0451US10519441B2Use of miRNA-214 inhibitor in inhibiting regulatory cellsJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2014·Granted Dec 31, 2019·0 cites·7 claims
- 0551US10155947B2Method for inhibiting Ebola virus via miRNAJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2015·Granted Dec 18, 2018·0 cites·8 claims
- 0650US10240150B2Avian influenza virus miRNA, and appraisal, detection, and application thereofJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2014·Granted Mar 26, 2019·0 cites·4 claims
- 0750US9909127B2Inhibitor for inhibiting avian influenza virus and a pharmaceutical composition containing the sameJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2014·Granted Mar 6, 2018·0 cites·3 claims
- 0848US2018201927A1Novel precursor mirna and application thereof in tumor treatmentJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2015·Application pending·0 cites
- 0942US10982213B2K-RAS gene expression-suppressing siRNA, precursor of same, and applications thereofJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2017·Granted Apr 20, 2021·0 cites·20 claims
- 1041US11304970B2EGFR gene expression-suppressing siRNA, precursor of same, and applications thereofJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2017·Granted Apr 19, 2022·0 cites·16 claims
- 1136US2017247696A1Microrna with placenta-permeability and uses thereofJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2015·Application pending·0 cites
- 1234US10273481B2SiRNA in tandem expression and uses thereof in treating chronic lymphocytic leukemiaJIANGSU MICROMEDMARK BIOTECH CO LTD·Filed 2015·Granted Apr 30, 2019·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when JIANGSU MICROMEDMARK BIOTECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →